Serzone is a prescription drug used to treat depression. It has been widely prescribed because of its lower incidence of some troublesome side effects (like sexual problems and insomnia) that are more common among other antidepressants. However, Serzone has been associated with an increased risk of liver failure, a serious and potentially life-threatening condition.
After repeatedly urging Serzone's manufacturer, Bristol-Myers Squibb Co., to provide physicians and patients with stronger warnings, the Food and Drug Administration finally required that a black box warning be added to Serzone's label. The order came in December 2001 after reports showed a three to four-times higher incidence of liver failure among Serzone patients than among the general public. Patients who experience liver failure may require a transplant and some will not survive the condition.
If you, or a loved one, have suffered liver damage as the result of taking Serzone, please contact us today.